journal
https://read.qxmd.com/read/39029479/us-supreme-court-overturns-chevron-doctrine
#61
JOURNAL ARTICLE
Bryant Furlow
No abstract text is available yet for this article.
September 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38876137/hypothermia-for-expanded-criteria-organ-donors-in-kidney-transplantation-in-france-hyporeme-a-multicentre-randomised-controlled-trial
#62
RANDOMIZED CONTROLLED TRIAL
(no author information available yet)
BACKGROUND: Expanded criteria donors help to increase graft availability, but provide organs with an increased risk of delayed graft function. We aimed to investigate whether donor hypothermia decreases the risk of delayed graft function compared with normothermia. METHODS: We did this multicentre, randomised, controlled, parallel-arm trial at 53 intensive care units and transplant centres in France. We included expanded criteria donors in whom death was diagnosed based on neurological criteria, in compliance with French law, and the recipients of their kidney grafts...
September 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/39089764/correction-to-lancet-respir-med-2024-12-642-54
#63
(no author information available yet)
No abstract text is available yet for this article.
August 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/39089763/the-recent-explosion-in-snortable-energy-powder-consumption
#64
LETTER
Jérémie Pourchez, Clément Mercier, Lara Leclerc, Valérie Forest
No abstract text is available yet for this article.
August 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/39089762/concerning-the-use-of-aminoglycosides-in-ventilator-associated-pneumonia-authors-reply
#65
LETTER
Srishti Chhabra, Yin Mo
No abstract text is available yet for this article.
August 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/39089761/concerning-the-use-of-aminoglycosides-in-ventilator-associated-pneumonia
#66
LETTER
Simone Y M de Jong, G Jan Zijlstra
No abstract text is available yet for this article.
August 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/39089760/household-air-pollution-a-neglected-threat
#67
EDITORIAL
The Lancet Respiratory Medicine
No abstract text is available yet for this article.
August 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38870979/garsorasib-in-patients-with-kras-g12c-mutated-non-small-cell-lung-cancer-in-china-an-open-label-multicentre-single-arm-phase-2-trial
#68
MULTICENTER STUDY
Ziming Li, Xiaomin Dang, Dingzhi Huang, Shi Jin, Weiwei Li, Jianhua Shi, Xicheng Wang, Yiping Zhang, Zhengbo Song, Junping Zhang, Wu Zhuang, Xuewen Liu, Liyan Jiang, Xiangjiao Meng, Mingfang Zhao, Jianying Zhou, Liangming Zhang, Pingli Wang, Hui Luo, Junquan Yang, Shundong Cang, Xiang Wang, Ling Zhang, Shun Lu
BACKGROUND: Garsorasib (D-1553; InventisBio, Shangai, China), a potent KRASG12C inhibitor, has shown promising antitumour activity in patients with KRASG12C -mutated (ie, Gly12Cys) non-small-cell lung cancer (NSCLC) in a phase 1 study. We report results from a phase 2 study conducted to evaluate the efficacy and safety of garsorasib in patients with locally advanced or metastatic KRASG12C -mutated NSCLC. METHODS: This open-label, multicentre, single-arm, phase 2 trial enrolled adult patients with KRASG12C -mutated NSCLC who had previously been treated with platinum-based chemotherapy and immune checkpoint inhibitors from 43 hospitals in China...
August 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38734022/effectiveness-of-preventive-treatment-among-different-age-groups-and-mycobacterium-tuberculosis-infection-status-a-systematic-review-and-individual-participant-data-meta-analysis-of-contact-tracing-studies
#69
JOURNAL ARTICLE
Leonardo Martinez, James A Seddon, C Robert Horsburgh, Christoph Lange, Anna M Mandalakas
BACKGROUND: Tuberculosis is a preventable disease. However, there is debate regarding which individuals would benefit most from tuberculosis preventive treatment and whether these benefits vary in settings with a high burden and low burden of tuberculosis. We aimed to compare the effectiveness of tuberculosis preventive treatment in exposed individuals of differing ages and Mycobacterium tuberculosis infection status while considering tuberculosis burden of the settings. METHODS: In this systematic review and individual-participant meta-analysis, we investigated the development of incident tuberculosis in people closely exposed to individuals with tuberculosis...
August 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38701817/long-term-outcomes-after-treatment-of-delirium-during-critical-illness-with-antipsychotics-mind-usa-a-randomised-placebo-controlled-phase-3-trial
#70
RANDOMIZED CONTROLLED TRIAL
Matthew F Mart, Leanne M Boehm, Amy L Kiehl, Michelle N Gong, Atul Malhotra, Robert L Owens, Babar A Khan, Margaret A Pisani, Gregory A Schmidt, R Duncan Hite, Matthew C Exline, Shannon S Carson, Catherine L Hough, Peter Rock, Ivor S Douglas, Daniel J Feinstein, Robert C Hyzy, William D Schweickert, David L Bowton, Andrew Masica, Onur M Orun, Rameela Raman, Brenda T Pun, Cayce Strength, Mark L Rolfsen, Pratik P Pandharipande, Nathan E Brummel, Christopher G Hughes, Mayur B Patel, Joanna L Stollings, E Wesley Ely, James C Jackson, Timothy D Girard
BACKGROUND: Delirium is common during critical illness and is associated with long-term cognitive impairment and disability. Antipsychotics are frequently used to treat delirium, but their effects on long-term outcomes are unknown. We aimed to investigate the effects of antipsychotic treatment of delirious, critically ill patients on long-term cognitive, functional, psychological, and quality-of-life outcomes. METHODS: This prespecified, long-term follow-up to the randomised, double-blind, placebo-controlled phase 3 MIND-USA Study was conducted in 16 hospitals throughout the USA...
August 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38991586/james-chalmers-a-maverick-making-an-impact-in-bronchiectasis
#71
JOURNAL ARTICLE
Peter Ranscombe
No abstract text is available yet for this article.
July 8, 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38991585/interactions-between-respiratory-syncytial-virus-and-streptococcus-pneumoniae-in-the-pathogenesis-of-childhood-respiratory-infections-a-systematic-review
#72
REVIEW
Sjanna B Besteman, Debby Bogaert, Louis Bont, Asuncion Mejias, Octavio Ramilo, Daniel M Weinberger, Ron Dagan
Lower respiratory tract infections, commonly caused by respiratory syncytial virus (RSV) or Streptococcus pneumoniae (pneumococcus), pose a substantial global health burden, especially in children younger than 5 years of age. A deeper understanding of the relationship between RSV and pneumococcus would aid the development of health-care approaches to disease prevention and management. We completed a systematic review to identify and assess evidence pertaining to the relationship between RSV and pneumococcus in the pathogenesis of childhood respiratory infections...
July 8, 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38971168/rethinking-bronchiectasis-as-an-inflammatory-disease
#73
REVIEW
Merete B Long, Sanjay H Chotirmall, Michal Shteinberg, James D Chalmers
Bronchiectasis is understood to be the result of a complex interaction between infection, impaired mucociliary clearance, inflammation, and lung damage. Current therapeutic approaches to bronchiectasis are heavily focused on management of infection along with enhancing mucus clearance. Long-term antibiotics have had limited success in clinical trials, suggesting a need to re-evaluate the concept of bronchiectasis as an infective disorder. We invoke the example of asthma, for which treatment paradigms shifted away from targeting smooth muscle constriction, towards permanently suppressing airway inflammation, reducing risk and ultimately inducing remission with precision anti-inflammatory treatments...
July 3, 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38936990/correction-to-lancet-respir-med-2024-12-544-55
#74
(no author information available yet)
No abstract text is available yet for this article.
July 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38851193/respiratory-syncytial-virus-vaccines-the-future-is-bright
#75
EDITORIAL
The Lancet Respiratory Medicine
No abstract text is available yet for this article.
July 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38788748/high-flow-nasal-oxygen-for-children-s-airway-surgery-to-reduce-hypoxaemic-events-a-randomised-controlled-trial
#76
RANDOMIZED CONTROLLED TRIAL
Susan Humphreys, Britta S von Ungern-Sternberg, Fiona Taverner, Andrew Davidson, Justin Skowno, Ben Hallett, David Sommerfield, Neil Hauser, Tara Williams, Susan Spall, Trang Pham, Tiffany Atkins, Mark Jones, Emma King, Laura Burgoyne, Philip Stephens, Shyan Vijayasekaran, Nicola Slee, Hannah Burns, Donna Franklin, Judith Hough, Andreas Schibler
BACKGROUND: Tubeless upper airway surgery in children is a complex procedure in which surgeons and anaesthetists share the same operating field. These procedures are often interrupted for rescue oxygen therapy. The efficacy of nasal high-flow oxygen to decrease the frequency of rescue interruptions in children undergoing upper airway surgery is unknown. METHODS: In this multicentre randomised trial conducted in five tertiary hospitals in Australia, children aged 0-16 years who required tubeless upper airway surgery were randomised (1:1) by a web-based randomisation tool to either nasal high-flow oxygen delivery or standard oxygen therapy (oxygen flows of up to 6 L/min)...
July 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38768624/re-evaluating-the-role-of-cpap-in-osa-management-amid-obesity-pharmacology-advancements
#77
JOURNAL ARTICLE
Neomi Shah
No abstract text is available yet for this article.
July 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38768623/continuous-positive-airway-pressure-is-here-to-stay
#78
JOURNAL ARTICLE
Atul Malhotra, Jeremy H Pettus
No abstract text is available yet for this article.
July 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38705167/seralutinib-in-adults-with-pulmonary-arterial-hypertension-torrey-a-randomised-double-blind-placebo-controlled-phase-2-trial
#79
RANDOMIZED CONTROLLED TRIAL
Robert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, Pilar Escribano Subías, Ronald L Zolty, Raymond L Benza, Richard N Channick, Kelly M Chin, Anna R Hemnes, Luke S Howard, Olivier Sitbon, Jean-Luc Vachiéry, Roham T Zamanian, Matt Cravets, Robert F Roscigno, David Mottola, Robin Osterhout, Jean-Marie Bruey, Erin Elman, Cindy-Ann Tompkins, Ed Parsley, Richard Aranda, Lawrence S Zisman, Hossein-Ardeschir Ghofrani
BACKGROUND: Morbidity and mortality in pulmonary arterial hypertension (PAH) remain high. Activation of platelet-derived growth factor receptor, colony stimulating factor 1 receptor, and mast or stem cell growth factor receptor kinases stimulates inflammatory, proliferative, and fibrotic pathways driving pulmonary vascular remodelling in PAH. Seralutinib, an inhaled kinase inhibitor, targets these pathways. We aimed to evaluate the efficacy and safety of seralutinib in patients with PAH receiving standard background therapy...
July 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38677306/chronic-respiratory-disease-in-indigenous-peoples-a-framework-to-address-inequity-and-strengthen-respiratory-health-and-health-care-globally
#80
REVIEW
Anne B Chang, Tom Kovesi, Gregory J Redding, Conroy Wong, Gonzalo G Alvarez, Rebecca Nantanda, Edgar Beltetón, Maynor Bravo-López, Maree Toombs, Paul J Torzillo, Diane M Gray
Indigenous peoples around the world bear a disproportionate burden of chronic respiratory diseases, which are associated with increased risks of morbidity and mortality. Despite the imperative to address global inequity, research focused on strengthening respiratory health in Indigenous peoples is lacking, particularly in low-income and middle-income countries. Drivers of the increased rates and severity of chronic respiratory diseases in Indigenous peoples include a high prevalence of risk factors (eg, prematurity, low birthweight, poor nutrition, air pollution, high burden of infections, and poverty) and poor access to appropriate diagnosis and care, which might be linked to colonisation and historical and current systemic racism...
July 2024: Lancet Respiratory Medicine
journal
journal
47869
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.